These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2549457)

  • 41. Intrathecal co-administration of morphine and nimodipine produces higher antinociceptive effect by synergistic interaction as evident by injecting different doses of each drug in rats.
    Gupta H; Verma D; Ahuja RK; Srivastava DN; Wadhwa S; Ray SB
    Eur J Pharmacol; 2007 Apr; 561(1-3):46-53. PubMed ID: 17320072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse.
    Xu JY; Tseng LF
    Eur J Pharmacol; 1994 Sep; 262(3):223-31. PubMed ID: 7813587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
    Miaskowski C; Taiwo YO; Levine JD
    Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bilateral intranigral microinjection of morphine and opioid peptides produces antinociception in rats.
    Baumeister AA; Hawkins MF; Anticich TG; Moore LL; Higgins TD
    Brain Res; 1987 May; 411(1):183-6. PubMed ID: 2886181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin.
    Heyman JS; Vaught JL; Mosberg HI; Haaseth RC; Porreca F
    Eur J Pharmacol; 1989 Jun; 165(1):1-10. PubMed ID: 2548877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of antinociceptive cross-tolerance between intracerebroventricularly administered beta-endorphin and morphine or DPDPE in mice.
    Suh HH; Tseng LF
    Life Sci; 1990; 46(11):759-65. PubMed ID: 2157119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mu-, but not delta-, opioid receptor-mediated antinociception in mice is attenuated by gamma-irradiation.
    Raffa RB; Mathiasen JR; Brown DQ
    Brain Res; 1988 May; 447(2):393-7. PubMed ID: 2839268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antinociception and cardiovascular responses produced by intravenous morphine: the role of vagal afferents.
    Randich A; Thurston CL; Ludwig PS; Timmerman MR; Gebhart GF
    Brain Res; 1991 Mar; 543(2):256-70. PubMed ID: 2059834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the analgesic activity of morphine, enkephalins and their synthetic analogues.
    Aloisi F; Scotti de Carolis A; Longo VG
    Isr J Med Sci; 1982 Jan; 18(1):183-6. PubMed ID: 7068340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. (D-met2, pro5)-enkephalinamide: a potent morphine-like analgesic.
    Székely JI; Rónai AZ; Dunai-Kovács Z; Miglécz E; Berzétri I; Bajusz S; Gráf L
    Eur J Pharmacol; 1977 Jun; 43(3):293-4. PubMed ID: 872884
    [No Abstract]   [Full Text] [Related]  

  • 52. The involvement of opioidergic and noradrenergic mechanisms in nefopam antinociception.
    Gray AM; Nevinson MJ; Sewell RD
    Eur J Pharmacol; 1999 Jan; 365(2-3):149-57. PubMed ID: 9988097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
    Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
    Lemberg KK; Kontinen VK; Siiskonen AO; Viljakka KM; Yli-Kauhaluoma JT; Korpi ER; Kalso EA
    Anesthesiology; 2006 Oct; 105(4):801-12. PubMed ID: 17006080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
    Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
    Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse.
    Suh HW; Chung KM; Kim YH; Huh SO; Song DK
    Neuropeptides; 1999 Apr; 33(2):121-9. PubMed ID: 10657481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of intrathecally infused morphine and lidocaine in rats (part I): synergistic antinociceptive effects.
    Saito Y; Kaneko M; Kirihara Y; Sakura S; Kosaka Y
    Anesthesiology; 1998 Dec; 89(6):1455-63. PubMed ID: 9856720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists.
    Murray CW; Cowan A
    J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Partial depletion of endogenous zinc level by (D-Pen2, D-Pen5)enkephalin in the rat brain.
    Gulya K; Kovács GL; Kása P
    Life Sci; 1991; 48(12):PL57-62. PubMed ID: 1848338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL; Mathiasen JR; Raffa RB
    J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.